SELEXIS

selexis-logo

Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients.

#People #Financial #Event #Website #More

SELEXIS

Social Links:

Industry:
Biotechnology Health Diagnostics

Founded:
2001-01-01

Address:
Plan-les-ouates, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.selexis.com

Total Employee:
11+

Status:
Active

Contact:
(022) 308-9360

Email Addresses:
[email protected]

Total Funding:
67.48 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome


Current Employees Featured

yemi-onakunle_image

Yemi Onakunle
Yemi Onakunle VP, Licensing and Business Development @ Selexis
VP, Licensing and Business Development
2011-12-01

alberto-garotti_image

Alberto Garotti
Alberto Garotti Chief Financial Officer @ Selexis
Chief Financial Officer
2018-01-01

not_available_image

Pierre-Alain Girod
Pierre-Alain Girod CSO @ Selexis
CSO

marco-bocci_image

Marco Bocci
Marco Bocci VP, Licensing and Business Development @ Selexis
VP, Licensing and Business Development

not_available_image

Regine Brokamp
Regine Brokamp COO @ Selexis
COO

Founder


igor-fisch_image

Igor Fisch

sebastian-desimone_image

Sebastian Desimone

Investors List

eurostars_image

Eurostars

Eurostars investment in Grant - Selexis

foundation-pour-l-innovation-technologique_image

Foundation for Technological Innovation (FIT)

Foundation for Technological Innovation (FIT) investment in Debt Financing - Selexis

Newest Events participated

biotech-week-boston-2019_event_image Participated in Biotech Week Boston 2019 on 2019-09-10 as sponsor

bioprocess-international-european-summit-2017_event_image Participated in BioProcess International European Summit 2017 on 2017-04-25 as sponsor

viral-safety-2017_event_image Participated in Viral Safety 2017 on 2017-04-25 as sponsor

cell-line-development-engineering-2017_event_image Participated in Cell Line Development & Engineering 2017 on 2017-04-24 as sponsor

Official Site Inspections

http://www.selexis.com

  • Host name: 199.60.103.166
  • IP address: 199.60.103.166
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Selexis"

JSR Life Sciences Announces Operational Consolidation โ€ฆ

May 31, 2023 KBIโ€™s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers Sunnyvale, Calif. -- (May 31, 2023) -- JSR Life Sciences today announced that โ€ฆSee details»

Selexis - Crunchbase Company Profile & Funding

Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the โ€ฆSee details»

KBI Biopharma, Selexis SA Merge as One Organization

Jun 5, 2023 and Selexis SA, a cell line development company, are consolidating as one organization under the KBI Biopharma name. The fusion is expected to enable integrated, solutions for customers, cell line development through โ€ฆSee details»

Press Release | JSR Life Sciences Agrees to Acquire Pioneering Cell ...

Jun 14, 2017 About Selexis SA Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing โ€ฆSee details»

Selexis SA - Crunchbase Company Profile & Funding

Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.See details»

KBI Biopharma and Selexis Hold Joint Ribbon Cutting โ€ฆ

Jul 6, 2022 The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities to serve the global demand for novel therapies. GENEVA, Switzerland, July 6, 2022 โ€” KBI Biopharma SA (KBI) โ€ฆSee details»

Selexis SA - Plan-les-Ouates, Switzerland

Selexis is a science-driven organization, founded on the academic interests and discoveries of its core scientific team in molecular biology, cellular physiology, and genetic engineering, and is โ€ฆSee details»

Selexis 2025 Company Profile: Valuation, Investors, โ€ฆ

Information on acquisition, funding, cap tables, investors, and executives for Selexis. Use the PitchBook Platform to explore the full profile.See details»

Selexis SA - VentureRadar

Swiss-based Selexis SA is a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development. ... Find out more about Selexis SA, Biotech, โ€ฆSee details»

Selexis SA - Drug pipelines, Patents, Clinical trials - Synapse

Selexisโ€™ proprietary cell line development platform will be branded as the SUREtechnology Platform. Mowery will continue to lead as CEO of the combined organization.See details»

Selexis Company Profile - Office Locations, Competitors ... - Craft

See insights on Selexis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

JSR Life Sciences Announces Operational Consolidation of KBI โ€ฆ

Sunnyvale, Calif. โ€“ (May 31, 2023) โ€“ JSR Life Sciences today announced that KBI Biopharma, Inc. (KBI) and Selexis SA are consolidating as one organization under the KBI Biopharma โ€ฆSee details»

Selexis - Products, Competitors, Financials, Employees, โ€ฆ

Selexis is a biotech company that specializes in mammalian (suspension-adapted CHO-K1) cell line generation. It specializes in drug discovery, cell line development, and biopharmaceutical โ€ฆSee details»

Selexis and KBI Biopharma Enter into Agreements with Immatics โ€ฆ

Jun 30, 2021 About Selexis SA Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions โ€ฆSee details»

Selexis S.A. - Great Place To Work

Selexis S.A. - Our cell line development timelines and innovation are unprecedented. This is our focus, which is why we do it best. Ultimately, we help companies get drugs to patients faster โ€ฆSee details»

Delving into the Latest Updates on Selexis SA with Synapse

Selexisโ€™ proprietary cell line development platform will be branded as the SUREtechnology Platform. Mowery will continue to lead as CEO of the combined organization.See details»

Mark Womack - CEO at Selexis | The Org

An organization builder with a track record of delivering unprecedented growth and profit in every role, Mark Womack is the Chief Executive Officer of Selexis. Before joining Selexis, Mark โ€ฆSee details»

Selexis - Contacts, Employees, Board Members, Advisors & Alumni

Selexis has 5 current employee profiles, including VP, Licensing and Business Development Yemi Onakunle.Selexis is a pioneering life science company.See details»

Selexis SA: Drug pipelines, Patents, Clinical trials - Synapse

May 28, 2023 Explore Selexis SA with its drug pipeline, therapeutic area, technology platform, 26 news, and 5 literature.See details»

Selexis โ€“ Swiss Biotech

The advanced technologies in protein expression by Selexis provide biotech and pharmaceutical companies with a rapid, stable, and cost-effective solution for the production of recombinant โ€ฆSee details»